University of Manchester spin-out Microbiosensor Ltd has been announced winner of the Start-up Award at the Medilink NorthWest Healthcare Business Awards 2016, with fellow spin-out, Manchester Imaging Ltd also receiving recognition as finalists.
Held at the Victoria Warehouse in Manchester on the 22nd February, The Medilink North West Awards celebrates innovation, growth and commercial success of organisations operating in Healthcare Technology and Life Sciences in the North West. As winners of the North West heat, Microbiosensor is automatically nominated for the 2016 National Medilink UK Awards.
Microbiosensor Ltd is developing novel point-of-care medical devices for detecting microbial infection. These devices act as an early warning system for infection and can even diagnose which antibiotics will be most effective in treating an emerging infection. This proprietary technology is inexpensive and robust, providing a clear ‘yes/no’ signal indicating if a clinically relevant level of infection has been reached, thereby enabling earlier intervention than would otherwise be possible.
Dr Curtis Dobson, co-founder, comments: “We are absolutely delighted to receive this award. This success reflects the dramatic progress Microbiosensor Ltd. has made over last 2 to 3 years in translating University research into a tangible product, with the potential to deliver substantial economic and healthcare impacts across Europe. The Award will give the team a further boost as we move forward with our ambitious plans to gain a CE mark for our first product this year.”
Manchester Imaging is an early stage spin-out developing image analysis and diagnostic software for the dental industry. Applications are being designed to identify dental decay and other potential problems earlier, empowering patients to look after their teeth more effectively and saving money for insurance companies and governments by reducing the need for dental restorations and repairs. The recognition comes on the back of recent seed investment by Mercia Fund Management (MFM).
CEO Tony Travers comments: “To be finalists at this stage of the business is a fantastic accolade. Manchester Imaging is to continue development of its core product portfolio, the services of which are a first for the dental care sector. We hope that, by empowering practitioners and patients to better identify potential problems, we will be able to save local services’ and insurers’ money, whilst ensuring that people have healthy teeth and gums right into old age.”
Both companies were spun out of the University by its agent for intellectual property commercialisation, UMIP. Dr Rich Ferrie, Director of Operations, comments: “I’m delighted that Medilink has recognised the potential of two of our portfolio companies. Microbiosensor and Manchester Imaging have bright futures and I am confident that the combination of great technology and strong committed management will lead to commercial success.”